ENTA
Price
$14.12
Change
+$0.18 (+1.29%)
Updated
Nov 28 closing price
Capitalization
407.54M
71 days until earnings call
Intraday BUY SELL Signals
KROS
Price
$17.48
Change
-$0.02 (-0.11%)
Updated
Nov 28 closing price
Capitalization
532.55M
94 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ENTA vs KROS

Header iconENTA vs KROS Comparison
Open Charts ENTA vs KROSBanner chart's image
Enanta Pharmaceuticals
Price$14.12
Change+$0.18 (+1.29%)
Volume$143.06K
Capitalization407.54M
Keros Therapeutics
Price$17.48
Change-$0.02 (-0.11%)
Volume$660.55K
Capitalization532.55M
ENTA vs KROS Comparison Chart in %
ENTA
Daily Signal:
Gain/Loss:
KROS
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ENTA vs. KROS commentary
Nov 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ENTA is a Hold and KROS is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 30, 2025
Stock price -- (ENTA: $14.12 vs. KROS: $17.48)
Brand notoriety: ENTA and KROS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ENTA: 16% vs. KROS: 60%
Market capitalization -- ENTA: $407.54M vs. KROS: $532.55M
ENTA [@Biotechnology] is valued at $407.54M. KROS’s [@Biotechnology] market capitalization is $532.55M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.02B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ENTA’s FA Score shows that 1 FA rating(s) are green whileKROS’s FA Score has 0 green FA rating(s).

  • ENTA’s FA Score: 1 green, 4 red.
  • KROS’s FA Score: 0 green, 5 red.
According to our system of comparison, ENTA is a better buy in the long-term than KROS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ENTA’s TA Score shows that 4 TA indicator(s) are bullish while KROS’s TA Score has 6 bullish TA indicator(s).

  • ENTA’s TA Score: 4 bullish, 4 bearish.
  • KROS’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, KROS is a better buy in the short-term than ENTA.

Price Growth

ENTA (@Biotechnology) experienced а +10.92% price change this week, while KROS (@Biotechnology) price change was +0.52% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.92%. For the same industry, the average monthly price growth was +1.16%, and the average quarterly price growth was +72.91%.

Reported Earning Dates

ENTA is expected to report earnings on Feb 09, 2026.

KROS is expected to report earnings on Mar 04, 2026.

Industries' Descriptions

@Biotechnology (+6.92% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KROS($533M) has a higher market cap than ENTA($408M). ENTA YTD gains are higher at: 145.565 vs. KROS (10.423). KROS has higher annual earnings (EBITDA): 25.5M vs. ENTA (-82.41M). KROS has more cash in the bank: 690M vs. ENTA (204M). KROS has less debt than ENTA: KROS (18M) vs ENTA (58M). KROS has higher revenues than ENTA: KROS (233M) vs ENTA (64.8M).
ENTAKROSENTA / KROS
Capitalization408M533M77%
EBITDA-82.41M25.5M-323%
Gain YTD145.56510.4231,397%
P/E RatioN/A11.21-
Revenue64.8M233M28%
Total Cash204M690M30%
Total Debt58M18M322%
FUNDAMENTALS RATINGS
ENTA: Fundamental Ratings
ENTA
OUTLOOK RATING
1..100
36
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ENTAKROS
RSI
ODDS (%)
Bearish Trend 3 days ago
78%
Bearish Trend 3 days ago
71%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
80%
Momentum
ODDS (%)
Bullish Trend 3 days ago
61%
Bullish Trend 3 days ago
83%
MACD
ODDS (%)
Bullish Trend 3 days ago
74%
Bullish Trend 3 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
81%
Advances
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 5 days ago
77%
Declines
ODDS (%)
Bearish Trend 12 days ago
83%
Bearish Trend 11 days ago
79%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
86%
Aroon
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
ENTA
Daily Signal:
Gain/Loss:
KROS
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VVORX24.580.28
+1.15%
Invesco Value Opportunities R
CAPTX12.250.09
+0.74%
Canterbury Portfolio Thermostat I
SGSCX35.430.25
+0.71%
DWS Global Small Cap S
AGRYX147.260.86
+0.59%
AB Growth Advisor
FCUDX20.840.07
+0.34%
NYLI PineStone U.S. Equity Class R6